Related by context. All words. (Click for frequent words.) 64 liver metastasis 63 cardiotoxic 63 thrombotic complications 63 Adjuvant chemotherapy 63 metastatic malignant 63 DFMO 62 cisplatin resistant 62 cardiotoxicity 62 Xelox 62 postoperative chemotherapy 62 thromboembolic disease 62 pCR 62 pegylated liposomal doxorubicin 62 Lisofylline 61 reinfarction 61 locoregional recurrence 61 recurrent metastatic 61 Lung transplantation 61 gefitinib Iressa 61 Hydroxyurea 61 chemoradiotherapy 61 cranial irradiation 61 preoperative chemotherapy 61 Combination therapy 61 rtPA 61 metastatic colorectal 61 Cetuximab 61 dexrazoxane 61 durable remissions 61 antiangiogenic therapy 61 erlotinib Tarceva 61 adjuvant radiotherapy 61 complete cytogenetic response 61 antioxidant supplementation 61 MS relapses 61 neurologic progression 61 FUSILEV enhances 60 pertuzumab 60 variceal hemorrhage 60 metastatic gastric 60 squamous cell lung cancer 60 beta blocker therapy 60 Doxil ® 60 perioperatively 60 metastatic kidney 60 chromium supplementation 60 cisplatin chemotherapy 60 oral clodronate 60 cediranib 60 diabetic kidney 60 arterial plaque buildup 60 Vidaza ® 60 relapsed SCLC 60 polyp recurrence 60 antithrombotic therapy 60 myocardial reperfusion 60 cirrhotic patients 60 refractory ischemia 60 androgen ablation 60 mTOR inhibition 60 ZOLINZA 60 lowering homocysteine 60 hepatic toxicity 59 adenoma recurrence 59 inhibit platelet aggregation 59 thrombotic events 59 Radical prostatectomy 59 BEXXAR Therapeutic Regimen 59 chemosensitivity 59 Immunosuppressive drugs 59 disease progression 59 lapatinib Tykerb 59 FOLFOX4 59 ticlopidine 59 ToGA 59 insulin sensitizing 59 riociguat 59 bevacizumab Avastin Genentech 59 intravenous cyclophosphamide 59 relapsed ovarian cancer 59 standard chemotherapy regimen 59 gemcitabine Gemzar 59 Subgroup analysis 59 efaproxiral 59 clinically insignificant 59 adjuvant radiation 59 Flexi Scope 59 prostate cancer CaP 59 autologous transplants 59 colon tumors 59 lipid lowering therapies 59 curative therapy 59 postoperative pulmonary 59 zoledronic acid Zometa 59 pain palliation 59 impair fertility 59 postoperative mortality 59 ximelagatran 59 chemoradiation therapy 59 cytoreductive surgery 59 antitumor effect 59 lymphomas leukemias 59 nonmelanoma skin cancers 59 CYT# potent vascular disrupting 59 antibody mediated 59 chemoembolization 59 fibrinolytic 59 endometrial hyperplasia 59 CMV disease 59 anti angiogenic agents 59 imatinib Gleevec 59 colorectal adenoma 59 cancerous colon polyps 59 colorectal tumor 59 allogeneic HSCT 59 colorectal carcinoma 59 ICD therapy 59 breast cancer recurrence 59 Vascugel ® 59 prednisone prednisolone 59 TACE 59 relapsed ALL 59 mycophenolate mofetil 59 idraparinux 59 mitochondrial toxicity 59 chemotherapy docetaxel 59 lung metastasis 58 HER2 overexpression 58 selenium supplementation 58 lung fibrosis 58 alteplase 58 KRAS mutant tumors 58 recurrent venous thromboembolism 58 renal toxicity 58 malignant ascites 58 MGd 58 sorafenib Nexavar 58 Cristofanilli 58 Darapladib 58 GnRH agonists 58 Platinol ® cisplatin 58 Hepatocellular Carcinoma HCC 58 XL# SAR# 58 hoFH patients 58 deep venous thromboses 58 octreotide LAR 58 gamma secretase inhibitor 58 galiximab 58 colorectal cancer liver metastases 58 prostate carcinoma 58 intracranial stenosis 58 oral Xeloda 58 bevacizumab Avastin 58 edifoligide 58 recurrent atrial fibrillation 58 androgen deprivation 58 antiplatelet therapies 58 inhibits tumor 58 intravascular hemolysis 58 transplanted islets 58 paricalcitol 58 adjuvant therapies 58 endostatin 58 thromboembolic events 58 cardiac toxicity 58 Dasatinib 58 neoadjuvant therapy 58 nephrotoxic 58 recurrent prostate cancer 58 microvascular complications 58 TAXUS Express Stent 58 cabazitaxel 58 neutropenic sepsis 58 antioxidant vitamin supplements 58 transgene expression 58 Seewaldt 58 clinically detectable 58 BRAF inhibitor 58 ovarian suppression 58 neointimal hyperplasia 58 EDARBI 58 PSADT 58 mTOR inhibitors 58 sunitinib Sutent 58 imatinib therapy 58 anti angiogenic therapy 58 BRCA deficient 58 IV bisphosphonates 58 Kinoid 58 PROCHYMAL 58 Bevacizumab Avastin 58 debulking surgery 58 Akt activation 58 nephrotoxicity 58 cetuximab Erbitux 58 immunosuppressive regimen 58 Mitomycin C 58 fondaparinux 58 LV dysfunction 58 Thrombotic thromboembolic complications 58 postoperative delirium 58 adalimumab Humira 58 premalignant lesion 58 Erythropoietic therapies may 58 overt nephropathy 58 Aplidin 58 peritoneal carcinomatosis 58 small molecule tyrosine 58 exemestane Aromasin 58 thrombolytic therapy 58 Azacitidine 58 corticosteroid dexamethasone 58 hematopoietic cancers 58 antiangiogenic agent 58 platelet inhibition 58 rituximab Rituxan 58 antiangiogenic agents 58 rFVIIa 58 grade glioma 58 hemorrhagic complications 58 IFN beta 58 HER2 positive breast 58 demonstrated antitumor activity 58 bleomycin 58 glomerular filtration 58 TTF Therapy 58 intensive statin therapy 58 HuMax EGFr 58 paclitaxel poliglumex 58 Her2 positive 58 docetaxel chemotherapy 58 LRP5 57 antitumor efficacy 57 polyp detection 57 peritoneal cancer 57 angiotensin receptor blockers ARBs 57 Losartan 57 HIV HCV coinfected 57 alkylating agent 57 elacytarabine 57 androgen suppression therapy 57 venous thromboembolic disease 57 Bevacizumab 57 serum phosphate 57 flavopiridol 57 untreated OSA 57 fenretinide 57 precancerous condition 57 pancreatic lung 57 Intravitreal 57 AA Amyloidosis 57 hepatocellular 57 thrombocytopenic 57 atorvastatin #mg 57 biochemical relapse 57 epirubicin 57 H. pylori eradication 57 leukemic cell 57 gastrointestinal stromal tumors GIST 57 MAGE A3 ASCI 57 glycated hemoglobin levels 57 cranial radiation 57 temsirolimus 57 doxorubicin Adriamycin 57 noscapine 57 Ivabradine 57 recombinant erythropoietin 57 angiogenesis inhibition 57 intensive lipid lowering 57 rebleeding 57 EGFR receptor 57 colorectal liver metastases 57 VEGF inhibition 57 motor neuron degeneration 57 Sentinel node biopsy 57 chemopreventive 57 Cabazitaxel 57 recurrent glioblastoma multiforme 57 chemoresistance 57 relapsed MM 57 DAPT 57 Pemetrexed 57 Androgen deprivation therapy 57 LMWH 57 taxane refractory 57 epithelial ovarian cancer 57 TMEM density 57 fulvestrant 57 platelet function 57 chemotherapeutic regimen 57 locoregional 57 testosterone supplementation 57 KRAS status 57 bezafibrate 57 oral FTY# 57 Campath alemtuzumab 57 inhibited tumor 57 PLX STROKE targeting 57 pamidronate 57 antihypertensive therapy 57 lowering blood glucose 57 operable breast cancer 57 bortezomib Velcade 57 intra arterial chemotherapy 57 ABVD 57 radiation therapy SBRT 57 platelet inhibitor 57 severe exacerbations 57 postoperative complication 57 renal flares 57 bone metastasis 57 colorectal tumors 57 surrogate endpoint 57 stratifying patients 57 platelet activation 57 deferiprone 57 mycophenolic acid 57 docetaxel Taxotere 57 mucosal healing 57 upper gastrointestinal bleeding 57 perioperative complications 57 axitinib 57 teriflunomide 57 neoadjuvant 57 paclitaxel Taxol 57 Vojo Vukovic MD Ph.D. 57 asymptomatic carotid stenosis 57 CHOP chemotherapy 57 graft occlusion 57 Belldegrun 57 Hypotension 57 pancreatic adenocarcinoma 57 FGFR2 gene 57 raloxifene Evista 57 isoproterenol 57 zoledronic acid 57 Sanofi Aventis Taxotere 57 angiogenesis inhibitor 57 imexon 57 malignant growths 57 olaparib 57 Liver transplantation 57 transthyretin 57 EGFR blockers 57 B7 H3 57 recurrent glioblastoma 57 Vidofludimus 57 tamoxifen Nolvadex ® 57 Roche Herceptin 57 Natalizumab 57 metachronous 57 uPA 57 induce remission 57 5-FU/LV 57 macrovascular events 57 MICARDIS ® 57 K ras mutations 57 morphometric vertebral fractures 57 artery reclogging 57 type 1diabetes 57 chronic thromboembolic pulmonary 57 plasma renin activity 57 SERCA2a 57 Caloric restriction 57 Metastatic colorectal cancer 57 Screening mammography 57 endometrial carcinoma 57 dose atorvastatin 57 Ovary removal 57 dosing frequency 57 radiotherapy RT 57 samalizumab 57 postoperative AF 57 Bezielle 57 mRCC 57 lactate dehydrogenase 57 thromboembolisms 57 Imatinib 57 coagulation parameters 57 artery stenosis 57 overlapping toxicities 57 basiliximab 57 B Cell Lymphoma 57 thromboembolism 57 PSA nadir 57 refractory ovarian cancer 57 cartilage degeneration 57 dissolving blood clots 57 perioperative mortality 57 transdermal estradiol 57 Torisel 57 hedgehog pathway 57 tyrosine kinase inhibitors 57 anastrozole 57 vidofludimus 57 EBRT 57 neutropenic 57 ATACAND 57 CMV infections 57 perioperative morbidity 57 antiresorptive 57 Fulvestrant 57 Alessandro Riva 57 systemic toxicity 57 ischemia induced 57 ixabepilone 57 GP IIb IIIa inhibitors 57 torsade de pointes 57 precursor lesions 57 variceal 57 cardiac dysfunction 57 response CCyR 57 recurrent myocardial infarction 56 Mofenson 56 ANAVEX #-# [001] 56 nonsmall cell lung cancer 56 5 Fluorouracil 56 cervical carcinoma 56 Vidaza azacitidine 56 cytoreduction 56 colorectal cancer CRC 56 cervical lesions 56 Procoralan 56 infliximab Remicade 56 Inhaled nitric oxide 56 ovarian carcinoma 56 pyridostigmine 56 Riluzole 56 nicardipine 56 interferon ribavirin 56 KRAS oncogene 56 indibulin 56 aromatase inhibitor therapy 56 endocrine therapies 56 Temsirolimus 56 homozygous familial hypercholesterolemia 56 Avandia Actos 56 coadministration 56 oral anticoagulant therapy 56 hepatocellular carcinoma liver 56 paroxysmal AF 56 antiarrhythmic drugs 56 prognostic indicator 56 LHRH agonists 56 EGFR TKI 56 ivabradine 56 ImmunoVEX HSV2 56 fibrinolysis 56 antiangiogenesis 56 Alpha lipoic acid 56 angiographic restenosis 56 erlotinib Tarceva ® 56 immunosuppressive regimens 56 advanced adenomas 56 activate p# 56 cerebral vasospasm 56 immunosuppressant drug 56 TMP SMX 56 neoadjuvant treatment 56 Cell Lymphoma CTCL 56 urothelial cancer 56 uric acid lowering 56 cancer mCRC 56 chemopreventive agent 56 BRCA mutation carriers 56 improves insulin sensitivity 56 Xanafide 56 Paraplatin ® 56 catheter angiography 56 elevated triglyceride levels 56 nonnucleoside reverse transcriptase inhibitors 56 BYSTOLIC 56 curable cancers 56 DHFR 56 biliary tract cancer 56 ErbB2 positive 56 CIMZIA ™ 56 chlamydial 56 Cisplatin 56 dasatinib Sprycel 56 induce regression 56 tumor regrowth 56 standard chemotherapy regimens 56 cinacalcet 56 KIF6 gene variant 56 COX2 56 TNF antagonist 56 Camptosar ® 56 pancreatic prostate 56 neutrophil counts 56 triglyceride concentrations 56 radiosensitivity 56 N acetylcysteine 56 inhibit platelet function 56 conventional angiography 56 dalteparin 56 intact parathyroid hormone 56 radiofrequency ablation RFA 56 trastuzumab Herceptin ® 56 radioiodine therapy 56 intracranial atherosclerosis 56 Ceplene/IL-2 56 argatroban 56 ancrod 56 acadesine 56 irinotecan chemotherapy 56 tumor progression 56 revascularisation 56 indomethacin 56 TAXOTERE ® 56 Anthracycline 56 chemoresistant 56 potentially hepatotoxic 56 β blockers 56 Intravenous immunoglobulin 56 radiographic progression 56 OHR/AVR# 56 thalidomide Thalomid 56 5-fluorouracil/leucovorin 56 Interferon beta 56 R0 resection 56 silent ischemia 56 suppresses tumor 56 serum calcium levels 56 clonogenic 56 nodal metastasis 56 cilengitide 56 tumor histology 56 polyomavirus nephropathy 56 PNH patients 56 Bresalier 56 cyclophosphamide Cytoxan 56 metastatic lung cancer 56 androgen suppression 56 patients receiving myelosuppressive 56 Elocalcitol 56 membranous nephropathy 56 radiochemotherapy 56 CMV reactivation 56 TNF alpha antagonist 56 heavily pretreated patients 56 induced neuropathy 56 GISTs 56 left ventricular dysfunction 56 curative resection 56 localized prostate 56 ductal cancer 56 ginkgo extract 56 DMARD 56 differentiated thyroid 56 lupus nephritis 56 Neoadjuvant 56 TAXOTERE R 56 antiandrogens 56 pelvic lymphadenectomy 56 decompensated cirrhosis 56 Abbott Trilipix 56 ezetimibe simvastatin 56 mutated KRAS gene 56 neoadjuvant chemotherapy 56 TRAIL induced apoptosis 56 corticosteroid therapy 56 Glaxo Tykerb 56 malignant transformation 56 graft patency 56 cardiac repolarization 56 E selectin 56 complement inhibitor eculizumab 56 Fluorouracil 56 CYP#D# inhibitor 56 chemoradiation 56 Gleevec resistant 56 PEGPH# 56 gemcitabine Gemzar ® 56 LTB4 56 topotecan 56 curability 56 non resectable metastatic 56 NSAID associated 56 Teriflunomide 56 antimicrobial prophylaxis 56 colorectal neoplasms 56 aspirin clopidogrel 56 maximally tolerated lipid lowering 56 Abiraterone 56 Vandetanib 56 bronchial inflammation 56 goserelin 56 recurrent bladder 56 intestinal mucosal 56 colorectal adenomas 56 visilizumab 56 fibrin deposition 56 anakinra 56 resistant hormone refractory 56 plasminogen activators 56 eribulin mesylate 56 Glioblastoma Multiforme 56 obstructive CAD 56 paclitaxel Taxol ® 56 diagnostic biomarker 56 mutated K ras 56 anti coagulant therapy 56 Shark cartilage 56 iniparib 56 FASLODEX 56 lactate dehydrogenase LDH 56 olmesartan 56 tachyarrhythmias 56 clopidogrel Plavix 56 BMPR2 56 sarcomatoid 56 carotid stenosis 56 Cholesterol lowering statins 56 liver scarring 56 acidic reflux 56 variceal bleeding 56 Sorafenib 56 azacitidine 55 TNFa 55 ELACYT 55 hemodialysis patients 55 myeloperoxidase 55 nitroprusside 55 idarubicin 55 unresectable tumors 55 serum biomarkers 55 temozolomide TMZ 55 SERMs 55 rt PA 55 Cimzia TM 55 cardiovascular hospitalizations 55 nonmetastatic 55 serum sodium levels 55 Pertuzumab 55 intracerebral haemorrhage 55 enzastaurin 55 fetal malformations 55 renoprotective 55 mammary tumor formation 55 metastatic GIST 55 intravenous tissue plasminogen 55 nonischemic 55 Kaplan Meier analysis 55 fluvastatin 55 receptor tyrosine kinase inhibitor 55 ACTEMRA TM 55 RBP4 levels 55 Noxafil 55 amifostine 55 haematologic 55 oral anticoagulation 55 Taxotere chemotherapy 55 surgical debulking 55 decitabine 55 esophageal candidiasis 55 Randomized trials 55 hormonally sensitive 55 arterial calcification 55 neurocognitive function 55 urate levels 55 indolent follicular non 55 tumor recurrence 55 Rev Dex 55 metastatic uveal melanoma 55 NMIBC 55 VAPRISOL 55 Lowering cholesterol 55 TroVax ® 55 tamoxifen therapy 55 lowers triglycerides 55 synthetic lethality 55 #.#ng/ml 55 Trastuzumab 55 inhibiting telomerase 55 revascularization procedure 55 mycophenolate mofetil MMF 55 histological subtype 55 Toxicities 55 anticlotting 55 Tyrima 55 liver resection 55 nonalcoholic steatohepatitis NASH 55 Cytoxan 55 Everolimus 55 hydroxychloroquine 55 aldosterone antagonists 55 heparin induced thrombocytopenia 55 reperfusion injury 55 liver histology 55 unruptured aneurysm 55 protamine 55 pharmacologic therapies 55 Carotid Revascularization Endarterectomy vs. 55 Endometrial 55 urothelial carcinoma 55 Femara letrozole 55 cardioprotective effects 55 genital herpes infections 55 lipid lowering therapy 55 coronary blockages 55 prostate tumor 55 Folfox 55 Cremophor 55 pre cancerous polyps 55 nonpharmacologic 55 minimally symptomatic 55 Velcade bortezomib 55 eplerenone 55 PROSTVAC VF 55 EUS FNA 55 Hormone Refractory Prostate Cancer 55 anthracycline taxane 55 apigenin 55 adriamycin 55 contralateral breast 55 probiotic supplementation 55 intestinal polyps 55 Aflibercept 55 clodronate 55 lipid lowering drugs 55 hepatotoxicity 55 skeletal metastases 55 Cardiotoxicity 55 CYP#D# genotype 55 platelet reactivity 55 eprotirome 55 imatinib resistance 55 nonvertebral fracture 55 #.#/#.# mmHg [001] 55 pentoxifylline 55 BRCA2 mutation carriers 55 alpha#beta# integrin 55 gemcitabine cisplatin 55 p# Shc 55 oral Hycamtin 55 liposomal doxorubicin 55 gastrointestinal perforation 55 gastrointestinal GI cancers 55 Chronic pancreatitis 55 cervical intraepithelial neoplasia 55 Notch1 55 elevated LDL cholesterol 55 postoperative radiotherapy 55 cardiovascular disease hypertension 55 Hodgkin lymphoma HL 55 BCIRG 55 Fludarabine 55 multiorgan 55 Eliezer Zomer Ph.D. 55 postoperative atrial fibrillation 55 epithelial barrier 55 axillary dissection 55 repolarization 55 Domchek 55 intratumoral 55 INTEGRILIN R 55 antiplatelet agent 55 Bortezomib 55 Hormonal therapy 55 bony metastases 55 anticancer therapy 55 Colorectal cancer screening 55 gastrointestinal stromal tumor GIST 55 fibrate drugs 55 kidney urologic 55 portal vein thrombosis 55 heparanase 55 fluorouracil 55 CTAP# Capsules 55 oral rivaroxaban 55 herceptin 55 triiodothyronine 55 cisplatin gemcitabine 55 doublet chemotherapy 55 infusional 55 mitral regurgitation MR 55 Dr. Ronald DePinho 55 thoracoscopic lobectomy 55 weekly subcutaneous injections 55 pretargeting 55 acute lymphoblastic 55 choroidal vasculopathy 55 invasive candidiasis 55 baseline LDH 55 chlamydial infection 55 lethal arrhythmias 55 oral antidiabetes 55 ALA PDT 55 precancerous cervical 55 hemoglobin A1c levels 55 HbA1C 55 systemically administered 55 Non inferiority 55 CIN2 + 55 NF kappaB activation 55 endoxifen 55 Novartis Zometa 55 ischemic complications 55 anthracycline containing 55 aP2 55 pediatric malignancies 55 XELOX 55 estramustine 55 antiplatelet therapy 55 inhibit metastasis 55 panitumumab Vectibix 55 postmenopausal breast cancer 55 Philip Mease 55 tamoxifen raloxifene 55 AChE inhibitors 55 transcranial Doppler ultrasound 55 antibiotic prophylaxis 55 p# activation 55 DCVax R 55 BH4 55 de ath 55 tyrosine kinase inhibitor 55 stem cell engraftment 55 refractory acute myeloid 55 Celecoxib 55 antithrombotic 55 CoFactor 55 taxane therapy 55 immune modulating 55 carotid artery blockage 55 PCa 55 AML MDS 55 cancerdefine 55 hypervascular tumors 55 apoptotic cell 55 Kaklamani 55 PAOD 55 smoldering multiple myeloma 55 lenalidomide dexamethasone 55 Ontak 55 systemic corticosteroid 55 Free Survival PFS 55 EXJADE 55 uterine tumors 55 pleural mesothelioma 55 chemotherapeutic drug 55 AGILECT R 55 metastatic androgen independent 55 Pegylated Interferon 55 immuno suppressive 55 Ascherio 55 serum phosphorous 55 WT1 55 Malignant Glioma 55 recombinant tissue plasminogen 55 valvulopathy 55 pegfilgrastim 55 carboplatin paclitaxel 55 microvascular disease 55 taxane chemotherapy administered 55 TNF blocker therapy 55 recurrent malignant glioma 55 xanthine oxidase inhibitor 55 EGFRIs 55 gene amplification 55 myocardial infarct size 55 protein excretion 55 Surgical resection 55 serum urate levels 55 selective modulator 55 Nicole Onetto MD 55 tryptase 55 hormone deprivation 55 thromboembolic 55 HNSCC 55 atheroma volume 55 neovascularisation 55 denileukin diftitox 55 atherosclerotic lesions 55 lowers LDL cholesterol 55 FOLFOX6 55 renal artery stenting 55 chlorambucil 55 breast endometrial 55 Soy isoflavones 55 BRCA carriers 55 recurrent VTE 55 parathyroid carcinoma 55 carotid atherosclerosis 55 Microalbuminuria 55 NNRTI resistance 55 antigen PSA levels 55 medically inoperable 55 thienopyridine 55 amyloid plaque formation 55 aurora kinase 55 BCG refractory 55 detecting precancerous 55 estrogen progestin combination 55 CA4P 55 VA# [002] 55 bicalutamide 55 coronary artery atherosclerosis 55 lenalidomide Revlimid R 55 uridine triacetate 55 Aclidinium 55 ZACTIMA 55 HIV lipodystrophy 55 Panzem NCD 55 neuroprotectant 55 Taxol paclitaxel 55 antiestrogen 55 fumagillin nanoparticles 55 beta adrenergic receptor 55 Cheson 55 canakinumab 55 bolus injection 55 Vincristine 55 CYPHER Stent 55 gadobutrol 55 symptomatic paroxysmal AF 55 salpingo oophorectomy 55 distal embolization 55 abiraterone 55 intrahepatic 55 hepatic fibrosis 55 Neuvenge 55 FDG-PET/CT 55 atherosclerosis regression 55 BRAF gene 55 malignant glioma brain tumor 55 Hurthle cell 55 BRCA1 BRCA2 55 angiotensin receptor blockers 55 antiplatelet medication 55 adjuvant tamoxifen 55 VT VF 55 HuLuc# 55 leukemia AML 55 EGF receptors 55 Teriparatide 55 renal dysfunction 54 eculizumab therapy 54 Aprotinin 54 Prostatitis 54 Arranon 54 figitumumab 54 cardiac troponin 54 hormone refractory metastatic prostate 54 erythropoietic 54 Irinotecan 54 Protelos 54 vinorelbine 54 OGG1 54 LHRH receptor positive 54 ICD implantation 54 glycoprotein IIb IIIa inhibitors 54 precancerous colon growths 54 prophylactic cranial irradiation 54 preoperative PSA 54 plasma triglycerides 54 salmeterol HFA MDI 54 Clot busting 54 aminotransferases 54 Gefitinib 54 intimal hyperplasia 54 plus dexamethasone 54 angiographically 54 Oxaliplatin 54 systemic hypotension 54 oncological outcomes 54 grade cervical dysplasia 54 atrial arrhythmias 54 mutated p# 54 DVT prophylaxis 54 steroid refractory GvHD 54 mitochondrial fusion 54 statins cholesterol lowering 54 grade cervical intraepithelial 54 reduce serum phosphate 54 biliary obstruction 54 lowering homocysteine levels 54 Pseudomonas aeruginosa infections 54 GnRH agonist 54 venous blood clots 54 non hodgkin lymphoma 54 mucinous 54 previously untreated follicular 54 multimodality therapy 54 talabostat 54 transdermal estrogen 54 cyclophosphamide chemotherapy 54 CP CPPS 54 taxane chemotherapy 54 treating neuropathic pain 54 ferroportin levels 54 androgen independent 54 NSAID induced GI 54 CINQUIL 54 statin medications 54 deCODE ProstateCancer TM 54 Lenalidomide 54 contrast induced nephropathy